Overview

Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if a drug called atorvastatin will reduce the size and stiffness of the muscle in the left ventricle of the heart.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Calgary
Collaborator:
Heart and Stroke Foundation of Canada
Treatments:
Atorvastatin
Atorvastatin Calcium
Criteria
Inclusion Criteria:

- 18 years and over with HCM in the absence of another cardiac or systemic disease
capable of producing a prespecified wall thickening

Exclusion Criteria:

- Required use of statin therapy or intolerance

- A clinical diagnosis of hypertension

- Indication for statin therapy for primary or secondary prevention of coronary artery
disease

- Current or anticipated indication in ≤ 1 year for implantable cardioverter
defibrillators or other metallic devices preventing cardiac magnetic resonance imaging
(MRI).